Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation
  • Ask Questions

Non-pharma applications

Share this:

  • LinkedIn
  • Facebook
  • Twitter
  • WhatsApp
  • Skype
  • Email

Like this:

Like Loading...

Recent Posts

  • Coronavirus Interplay With Lipid Rafts and Autophagy Unveils Promising Therapeutic Targets.
  • Cyclodextrin-impregnated masks to prevent the transmission of coronavirus
  • Marinus Awarded BARDA Contract to Develop SBECD-enabled Ganaxolone for Treatment of Refractory Status Epilepticus
  • Cyclodextrin counteracts obesity associated with various diseases including susceptibility for Covid-19
  • Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds: a patent evaluation of US2019343869(A1)

Tags

antiviral Betadex Sulfobutyl Ether Sodium Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 Dexolve drug delivery drug delivery systems Drugs Environment FDA Food Gilead HPBCD Nanoparticles nanotechnology Niemann Pick Disease NPC Polymer RAMEB remdesivir SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (6)
  • Analysis (11)
  • CD as API (77)
  • CD derivatives (98)
  • Cosmetics and toilettry (9)
  • Drug delivery (139)
  • E-ducation (34)
  • Environmental (29)
  • Events (85)
  • Food (44)
  • Gene delivery (6)
  • In Hungarian (2)
  • Non-pharma applications (71)
  • Other industrial use (25)
  • Pharma applications (267)
  • Supramolecular systems (7)
  • Uncategorized (22)

Top Posts

  • Coronavirus Interplay With Lipid Rafts and Autophagy Unveils Promising Therapeutic Targets.
  • Cyclodextrin-impregnated masks to prevent the transmission of coronavirus
  • EMA's recommendation on compassionate use of SBECD-enabled remdesivir for COVID-19 and Update from Gilead
  • Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds: a patent evaluation of US2019343869(A1)
  • Different cyclodextrins to treat NPC
  • Cyclodextrin counteracts obesity associated with various diseases including susceptibility for Covid-19
  • Potential COVID-19 therapeutics from a rare disease: utilization of lipid dysregulation to combat viral infectivity
  • Marinus Awarded BARDA Contract to Develop SBECD-enabled Ganaxolone for Treatment of Refractory Status Epilepticus
  • The monograph of SBECD is official in the European Pharmacopeia
  • Effect of CD on the antiaging drug: rapamycin

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 263 other subscribers

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
%d bloggers like this: